Hofmann M - Search Results

1

Positron emission tomography with 11C-acetate and 18F-FDG in prostate cancer patients.

Fricke E, Machtens S, Hofmann M, van den Hoff J, Bergh S, Brunkhorst T, Meyer GJ, Karstens JH, Knapp WH, Boerner AR. Fricke E, et al. Among authors: hofmann m. Eur J Nucl Med Mol Imaging. 2003 Apr;30(4):607-11. doi: 10.1007/s00259-002-1104-y. Epub 2003 Feb 13. Eur J Nucl Med Mol Imaging. 2003. PMID: 12589476 Clinical Trial.

2

Monitoring isotretinoin therapy in thyroid cancer using 18F-FDG PET.

Boerner AR, Petrich T, Weckesser E, Fricke H, Hofmann M, Otto D, Weckesser M, Langen KJ, Knapp WH. Boerner AR, et al. Among authors: hofmann m. Eur J Nucl Med Mol Imaging. 2002 Feb;29(2):231-6. doi: 10.1007/s00259-001-0702-4. Eur J Nucl Med Mol Imaging. 2002. PMID: 11926385

3

Influence of rhTSH on [(18)F]fluorodeoxyglucose uptake by differentiated thyroid carcinoma.

Petrich T, Börner AR, Otto D, Hofmann M, Knapp WH. Petrich T, et al. Among authors: hofmann m. Eur J Nucl Med Mol Imaging. 2002 May;29(5):641-7. doi: 10.1007/s00259-001-0745-6. Epub 2002 Feb 27. Eur J Nucl Med Mol Imaging. 2002. PMID: 11976802 Clinical Trial.

4

Pre-operative localisation of hyperfunctional parathyroid tissue with 11C-methionine PET.

Otto D, Boerner AR, Hofmann M, Brunkhorst T, Meyer GJ, Petrich T, Scheumann GF, Knapp WH. Otto D, et al. Among authors: hofmann m. Eur J Nucl Med Mol Imaging. 2004 Oct;31(10):1405-12. doi: 10.1007/s00259-004-1610-1. Epub 2004 Jul 29. Eur J Nucl Med Mol Imaging. 2004. PMID: 15278308 Clinical Trial.

5

[Positron emission tomography (PET) for diagnosis and monitoring of treatment for urological tumors].

Machtens S, Boerner AR, Hofmann M, Knapp WH, Jonas U. Machtens S, et al. Among authors: hofmann m. Urologe A. 2004 Nov;43(11):1397-409. doi: 10.1007/s00120-004-0714-3. Urologe A. 2004. PMID: 15502907 Review. German.

6

Outcome after radioiodine therapy in 107 patients with differentiated thyroid carcinoma and initial bone metastases: side-effects and influence of age.

Petrich T, Widjaja A, Musholt TJ, Hofmann M, Brunkhorst T, Ehrenheim C, Oetting G, Knapp WH. Petrich T, et al. Among authors: hofmann m. Eur J Nucl Med. 2001 Feb;28(2):203-8. doi: 10.1007/s002590000420. Eur J Nucl Med. 2001. PMID: 11303891 Clinical Trial.

7

[Follow-up of differentiated thyroid cancer patients using rhTSH--preliminary results].

Petrich T, Börner AR, Weckesser E, Soudah B, Otto D, Widjaja A, Hofmann M, Kreipe HH, Knapp WH. Petrich T, et al. Among authors: hofmann m. Nuklearmedizin. 2001 Feb;40(1):7-14. Nuklearmedizin. 2001. PMID: 11373937 German.

8

68Ga-labelled DOTA-derivatised peptide ligands.

Meyer GJ, Mäcke H, Schuhmacher J, Knapp WH, Hofmann M. Meyer GJ, et al. Among authors: hofmann m. Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1097-104. doi: 10.1007/s00259-004-1486-0. Epub 2004 Mar 17. Eur J Nucl Med Mol Imaging. 2004. PMID: 15029459

9

Use of recovery coefficients as a test of system linearity of response in positron emission tomography (PET).

Knoop BO, Geworski L, Hofmann M, Munz DL, Knapp WH. Knoop BO, et al. Among authors: hofmann m. Phys Med Biol. 2002 Apr 21;47(8):1237-54. doi: 10.1088/0031-9155/47/8/302. Phys Med Biol. 2002. PMID: 12030553

10

In vivo monitoring of natural killer cell-dependent clearance of lung metastasis using dynamic positron emission tomography.

Kruschinski C, Hama Y, Skripuletz T, Vaske B, Knapp WH, Schmidt RE, Pabst R, von Hörsten S, Hofmann M. Kruschinski C, et al. Among authors: hofmann m. In Vivo. 2012 Mar-Apr;26(2):191-5. In Vivo. 2012. PMID: 22351657

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,653 results

Search Page

Filters